Actinium Pharmaceuticals, Inc. - stock earnings
ATNM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -13.3 million USD | ? USD |
| 2023Q2 | -15.2 million USD | ? USD |
| 2023Q1 | -10.5 million USD | ? USD |
| 2022Q4 | -10.0 million USD | 114000 USD |
| 2022Q3 | -9.1 million USD | 45000 USD |
| 2022Q2 | -7.7 million USD | 45000 USD |
| 2022Q1 | -5.1 million USD | 940000 USD |
| 2021Q4 | -8.0 million USD | 23000 USD |
| 2021Q3 | -6.4 million USD | 233000 USD |
| 2021Q2 | -5.0 million USD | 266000 USD |
| 2021Q1 | -5.3 million USD | 622000 USD |
| 2020Q4 | -6.4 million USD | ? USD |
| 2020Q3 | -5.5 million USD | ? USD |
| 2020Q2 | -4.6 million USD | ? USD |
| 2020Q1 | -4.6 million USD | ? USD |
| 2019Q4 | -4.6 million USD | ? USD |
| 2019Q3 | -6.6 million USD | ? USD |
| 2019Q2 | -5.0 million USD | ? USD |
| 2019Q1 | -5.7 million USD | ? USD |
| 2018Q4 | -6.3 million USD | ? USD |
| 2018Q3 | -6.1 million USD | ? USD |
| 2018Q2 | -4.9 million USD | ? USD |
| 2018Q1 | -6.3 million USD | ? USD |
| 2017Q4 | -5.2 million USD | ? USD |
| 2017Q3 | -6.3 million USD | ? USD |
| 2017Q2 | -7.1 million USD | ? USD |
| 2017Q1 | -8.1 million USD | ? USD |
| 2016Q4 | -6.7 million USD | ? USD |
| 2016Q3 | -6.6 million USD | ? USD |
| 2016Q2 | -6.6 million USD | ? USD |
| 2016Q1 | -4.4 million USD | ? USD |
| 2015Q4 | -6.5 million USD | ? USD |
| 2015Q3 | -3.9 million USD | ? USD |
| 2015Q2 | -7.5 million USD | ? USD |
| 2015Q1 | -3.1 million USD | ? USD |
| 2014Q4 | -5.4 million USD | ? USD |
| 2014Q3 | -6.1 million USD | ? USD |
| 2014Q2 | 3.5 million USD | ? USD |
| 2014Q1 | -16.7 million USD | ? USD |
| 2013Q4 | -5.9 million USD | ? USD |
| 2013Q3 | -1.4 million USD | ? USD |
| 2013Q2 | -2.8 million USD | ? USD |
| 2013Q1 | -689027 USD | ? USD |
| 2012Q4 | -8.3 million USD | ? USD |
| 2012Q3 | -3.0 million USD | ? USD |
| 2012Q2 | -1.6 million USD | ? USD |
| 2012Q1 | -2647 USD | ? USD |
| 2011Q4 | -2647 USD | ? USD |
| 2011Q3 | -3514 USD | ? USD |
| 2011Q2 | 20455 USD | ? USD |
| 2011Q1 | -4005 USD | ? USD |
| 2010Q4 | -8522 USD | ? USD |
| 2010Q3 | -9679 USD | ? USD |
| 2010Q2 | 28171 USD | ? USD |
| 2010Q1 | -8296 USD | ? USD |
| 2009Q4 | -9497 USD | ? USD |
| 2009Q3 | -3849 USD | ? USD |
| 2009Q2 | -3672 USD | ? USD |
| 2009Q1 | -5313 USD | ? USD |
| 2008Q4 | -7612 USD | ? USD |
| 2008Q3 | -3330 USD | ? USD |
| 2008Q2 | -9473 USD | ? USD |
| 2008Q1 | -10828 USD | ? USD |
| 2007Q4 | -4637 USD | ? USD |
| 2007Q3 | -6353 USD | ? USD |
| 2007Q2 | -3375 USD | ? USD |
| 2007Q1 | -435 USD | ? USD |
| 2006Q4 | -8374 USD | ? USD |
| 2006Q3 | -9812 USD | ? USD |
ATNM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -50.1 million USD | ? USD |
| 2022 | -31.9 million USD | 1.0 million USD |
| 2021 | -24.6 million USD | 1.1 million USD |
| 2020 | -22.0 million USD | 622000 USD |
| 2019 | -21.7 million USD | ? USD |
| 2018 | -23.7 million USD | ? USD |
| 2017 | -26.6 million USD | ? USD |
| 2016 | -24.3 million USD | ? USD |
| 2015 | -21.0 million USD | ? USD |
| 2014 | -24.7 million USD | ? USD |
| 2013 | -10.8 million USD | ? USD |
| 2012 | -8.4 million USD | ? USD |
| 2011 | 10289 USD | ? USD |
| 2010 | 1674 USD | ? USD |
| 2009 | -22331 USD | ? USD |
| 2008 | -31243 USD | ? USD |
| 2007 | -14800 USD | ? USD |
| 2006 | -18404 USD | ? USD |
ATNM
Price: $8.96
52 week price:
Earnings Per Share: -1.93 USD
P/E Ratio: -2.83
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 219900
Market Capitalization: 246.7 million